These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15631561)

  • 1. Long-term effects of lifestyle behavior change in coronary artery disease: effects on recurrent coronary events after percutaneous coronary intervention.
    Lisspers J; Sundin O; Ohman A; Hofman-Bang C; Rydén L; Nygren A
    Health Psychol; 2005 Jan; 24(1):41-8. PubMed ID: 15631561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The short- and long-term motivational effects of a patient education programme for patients with coronary artery bypass grafting].
    Krannich JH; Weyers P; Lueger S; Faller H; Schimmer C; Deeg P; Elert O; Leyh R
    Rehabilitation (Stuttg); 2008 Aug; 47(4):219-25. PubMed ID: 18704871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty. A randomized study of a multifactorial programme.
    Hofman-Bang C; Lisspers J; Nordlander R; Nygren A; Sundin O; Ohman A; Rydén L
    Eur Heart J; 1999 Oct; 20(20):1465-74. PubMed ID: 10493845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome.
    Chyrchel M; Rakowski T; Rzeszutko L; Legutko J; Dziewierz A; Dubiel JS; Dudek D
    Kardiol Pol; 2006 Dec; 64(12):1357-62; discussion 1363. PubMed ID: 17206539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of treating exhaustion in angioplasty patients on new coronary events: results of the randomized Exhaustion Intervention Trial (EXIT).
    Appels A; Bär F; van der Pol G; Erdman R; Assman M; Trijsburg W; van Diest R; van Dixhoorn J; Mendes de Leon C
    Psychosom Med; 2005; 67(2):217-23. PubMed ID: 15784786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
    Gurfinkel EP; Perez de la Hoz R; Brito VM; Duronto E; Dabbous OH; Gore JM; Anderson FA;
    Int J Cardiol; 2007 Jun; 119(1):65-72. PubMed ID: 17045681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft.
    Mehta RH; Honeycutt E; Peterson ED; Granger CB; Halabi AR; Shaw LK; Smith PK; Califf RM; Harrington RA; Sketch MH
    Circulation; 2006 Jul; 114(1 Suppl):I396-401. PubMed ID: 16820607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
    Lewis BS; Mehta SR; Fox KA; Halon DA; Zhao F; Peters RJ; Keltai M; Budaj A; Yusuf S;
    Am Heart J; 2005 Dec; 150(6):1177-84. PubMed ID: 16338255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Percutaneous and surgical revascularization in acute coronary syndromes without persistent ST segment elevation. One-year outcome of 361 patients assigned to early invasive strategy].
    Szyguła-Jurkiewicz B; Wilczek K; Przybylski R; Pacholewicz J; Trzeciak P; Styn T; Zembala M; Poloński L
    Przegl Lek; 2004; 61(12):1295-300. PubMed ID: 15850316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network.
    Giannuzzi P; Temporelli PL; Marchioli R; Maggioni AP; Balestroni G; Ceci V; Chieffo C; Gattone M; Griffo R; Schweiger C; Tavazzi L; Urbinati S; Valagussa F; Vanuzzo D;
    Arch Intern Med; 2008 Nov; 168(20):2194-204. PubMed ID: 19001195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction.
    Chen LY; Lennon RJ; Grantham JA; Berger PB; Mathew V; Singh M; Holmes DR; Rihal CS
    Am J Cardiol; 2005 Feb; 95(3):349-54. PubMed ID: 15670543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
    Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH
    J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing psychosocial stress: a novel mechanism of improving survival from exercise training.
    Milani RV; Lavie CJ
    Am J Med; 2009 Oct; 122(10):931-8. PubMed ID: 19682669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in the outcome of cardiac interventions.
    Tillmanns H; Waas W; Voss R; Grempels E; Hölschermann H; Haberbosch W; Waldecker B
    Herz; 2005 Aug; 30(5):375-89. PubMed ID: 16132240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of off-pump coronary artery bypass grafting with percutaneous coronary intervention versus drug-eluting stents for three-vessel coronary artery disease.
    Yi G; Youn YN; Yoo KJ; Hong YS
    Ann Thorac Surg; 2008 Nov; 86(5):1438-43. PubMed ID: 19049727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health related quality of life after percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with acute coronary syndromes without ST-segment elevation. 12-month follow up.
    Szygula-Jurkiewicz B; Zembala M; Wilczek K; Wojnicz R; Polonski L
    Eur J Cardiothorac Surg; 2005 May; 27(5):882-6. PubMed ID: 15848330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of patients with prior percutaneous revascularization undergoing repeat coronary intervention (from the PRESTO Trial).
    Arjomand H; Willerson JT; Holmes DR; Bamlet WR; Surabhi SK; Roukoz B; Espinoza A; McClelland RL; McCormick DJ; Goldberg S;
    Am J Cardiol; 2005 Sep; 96(6):741-6. PubMed ID: 16169350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion.
    Brodie BR; VerSteeg DS; Brodie MM; Hansen C; Richter SJ; Stuckey TD; Gupta N; Pulsipher M; Downey W
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):504-9. PubMed ID: 15988742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.